GENE ONLINE|News &
Opinion
Blog

Opioid
Trials & Approvals Overdose
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Special Opioid
Walmart To Settle Opioid Lawsuits with $3.1 Billion, U.S. Government Mulls OTC Naloxone
2022-11-15
M&A Opioid
Indivior Buys Opiant For $145 Million, Adds Opioid Overdose Treatments To Portfolio
2022-11-15
Policy Opioid
CDC Unveils Updated Set of Opioid Prescription Guidelines
2022-11-04
Regulatory Overdose
Compensating for OxyContin: The Harm from Pharma
2022-04-12
Funding Pain Management
Allay Therapeutics Raises $60 Million to Finance its Non-Opioid Pain Management Platform
2021-09-16
Feature Cannabidiol
Spotlight: Cannabidiol (CBD) Based Medication Heralds New Promise in Neurological Therapies
2020-09-22
Trials & Approvals Pain Management
Trevena Inc. Gives Oliceridine Approval Another Shot
2020-02-11
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top